AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06214975 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EXOPULSE Mollii Suit Stimulation
Description: We designed a randomized crossover, sham-controlled, double-blind trial to demonstrate the improvement of motor functions and stroke related symptoms following a single session of active versus sham EXOPULSE Mollii suit stimulation. in phase 1, the patient will receive two stimulations separated by a two-week washout period. The patients will be randomized to receive either active/sham or sham/active and both patients and investigators will be blinded to the order in which the stimulation will be given. A 2-week washout period should be enough to prevent a potential carry over effect. Two weeks after the end of phase 1, a second open label phase (phase 2) of this trial will be proposed to all patients where they will receive active stimulation every other day at home over four weeks (for a total of 14 sessions). This will help understand the long term effects of EXOPULSE Mollii suit stimulation on stroke related symptoms.
Study NCT06214975 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: EXOPULSE Mollii Suit Stimulation
Description: We designed a randomized crossover, sham-controlled, double-blind trial to demonstrate the improvement of motor functions and stroke related symptoms following a single session of active versus sham EXOPULSE Mollii suit stimulation. in phase 1, the patient will receive two stimulations separated by a two-week washout period. The patients will be randomized to receive either active/sham or sham/active and both patients and investigators will be blinded to the order in which the stimulation will be given. A 2-week washout period should be enough to prevent a potential carry over effect. Two weeks after the end of phase 1, a second open label phase (phase 2) of this trial will be proposed to all patients where they will receive active stimulation every other day at home over four weeks (for a total of 14 sessions). This will help understand the long term effects of EXOPULSE Mollii suit stimulation on stroke related symptoms.
Study NCT06352580 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: 26 survey questions were administered face to face to parents, which they could answer in a short time.
Study NCT04834817 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Celluma POD
Description: A blue and near infrared handheld LED device
Study NCT05004571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EQU-001
Description: EQU-001 in 10 and 20 mg capsules
Study NCT05004571 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo
Study NCT06118385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEN8744
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.
Study NCT06118385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.
Study NCT05805423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: bilateral superficial cervical plexus blocks and local wound infiltration
Description: 10mL bupivacaine at Erb's point bilaterally and 10mL 0.25% Bupicacaine at incision
Study NCT05805423 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: placebo injection and local wound infiltration
Description: 10mL normal saline at Erb's point bilaterally and 10mL 0.25% Bupicacaine at incision
Study NCT05532644 — intervention group
Intervention type: OTHER
Intervention: AD drugs
Description: AD drugs
Study NCT06430697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paracetamol administration
Description: Patient hospitalized in Intensive Care Unit with a continuous measurement of blood pressure with a catheter and who have an administration of paracetamol by intravenous or per os
Study NCT05534217 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: corneal debridement of corneal abrasion
Description: Surgical debridement for traumatic corneal epithelial abrasions
Study NCT05534217 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: corneal debridement of corneal abrasion
Description: Surgical debridement for traumatic corneal epithelial abrasions
Study NCT04875013 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with dynamic posturography
Description: Rehabilitation exercises guided by an interactive display and measured by a footplate sensor
Study NCT05118191 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: OOLER
Description: Following the baseline block (first four weeks), participants will use the OOLER device to power a cooling mattress pad each night during sleep for four weeks.
Study NCT05118191 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EmbrWave
Description: Following the baseline block (first four weeks), participants will use the Embr Wave 2 device to provide pulsed warm sensations to the inner wrist each night during sleep for four weeks.
Study NCT04809012 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: STI-3031
Description: STI-3031 is an anti-PD-L1 antibody
Study NCT05110638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKX-16 (Luliconazole 10% Solution)
Description: SKX-16 (Luliconazole 10% Solution) will be applied to each toenail and periungual areas once daily for 29 days such that there is sufficient quantity of solution to treat all toenails. All ten toes will be treated regardless of whether affected. The applications will occur in the clinic and be applied by study personnel. The nails will remain exposed until the applied solution dries.
Study NCT06408662 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mindfulness-based intervention for tics (MBIT)
Description: Psychological intervention that focuses on cultivating awareness of urges to tic and developing a different relationship to those urges through meditation and other mindfulness practice
Study NCT06408662 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: psychoeducation with relaxation and supportive therapy (PRST)
Description: Psychological Intervention that focuses on learning more about tics, practicing a range of strategies for coping with tics (e.g., relaxation, effective communication), and discussing challenges commonly experienced by individuals with tics.
Study NCT05354817 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: mFOLFIRINOX
Description: mFOLFIRINOX: - Oxaliplatin; Leucovorin; Irinotecan and 5-FU
Study NCT05075330 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Opioid Use Disorder Stigma Reduction
Description: Billboards with destigmatizing language regarding opioid use disorder placed in the community.
Study NCT06378775 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary Artery Bypass Graft
Description: Coronary Artery Bypass Graft
Study NCT06378775 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotically-assisted minimally-invasive direct coronary artery bypass
Description: Robotically-assisted minimally-invasive direct coronary artery bypass
Study NCT06378775 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention
Description: Percutaneous Coronary Intervention
Study NCT05919342 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: NT-proBNP
Description: Patients will undergo an NT-proBNP which will guide their future involvement within the study. Patients with an NT-proBNP of ≥125 pg/mL will undergo transthoracic echocardiogram along with a clinical assessment - any diagnosis of HF will result in patients undergoing referral for initiation of guideline directed medical therapy (for HF).
Study NCT04778735 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Liver Transplantation
Description: Liver Transplantation is performed under spesific conditions to increase the life time of patients with liver diseases.
Study NCT05903508 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional task training and functional therapy program
Description: Functional task training group this will receive walking and no walking activities
Study NCT05903508 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional therapy program Group
Description: Functional therapy program Group this will receive goal directed training
Study NCT06706388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nL-ATN1-002
Description: Personalized antisense oligonucleotide
Study NCT05513326 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises and education
Description: Exercises: 3 training sessions per week that will last for 30 minutes. Sessions will start with 5 minutes of activation (walking on a treadmill or cycling). Then, participants will be asked to complete 5 exercises targeting lower limb strengthening (time: 18 minutes) followed by 2 exercises designed to improve balance and 3 stretching exercises for the lower limb (time: 7 minutes).~Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.
Study NCT05513326 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Education alone
Description: Education: Two one-on-one sessions (during week 2 and week 4 assessments) during which participants will receive information directly related to LSS and NC using illustration and videos. Participants will also be invited to ask their questions.
Study NCT05754034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High flow oxygen
Description: humidified and heated oxygen delivered at high flow rates via nasal cannula, with protocol to target SpO2 90-94%
Study NCT05754034 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard flow oxygen
Description: oxygen delivered at standard flow rates via nasal cannula, facemask, or nonrebreather mask, with protocol to target SpO2 90-94%
Study NCT05262075 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online Mindfulness Resiliency Program
Description: An approximate 20 minute online mindfulness resiliency program offered 3/wk x 4 weeks.
Study NCT05398367 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Galactagogue Supplement for Treatment of Low Milk Supply
Description: Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply
Study NCT05398367 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Galactagogue Supplement for Treatment of Low Milk Supply
Description: Participants will consume a commercially available dietary supplement on the market for augmentation of breast milk production in lactating women with low milk supply
Study NCT06515587 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lewis genotype detection reagent
Description: By evaluating the results of the Lewis gene test combined with the CA19-9 test, different subtypes of pancreatic cancer patients were differentiated to evaluate the prognosis
Study NCT06086509 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: Children were played music during computerized tomography.
Study NCT06525285 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective tissue graft wall technique
Description: Harvested connective tissue graft will be placed over the exposed root surface like a wall to cover the gingival recession
Study NCT06525285 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Connective tissue graft wall technique
Description: Harvested connective tissue graft will be placed over the exposed root surface like a wall to cover the gingival recession
Study NCT05887869 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth solution
Description: Telehealth solution offered for nutrition education and breastfeeding support.
Study NCT05077826 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: North Coast Medical Activadose II
Description: tES device model Activadose II (North Coast Medical, Morgan Hill, CA, USA) programed to deliver tES.
Study NCT05077826 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: North Coast Medical Activadose II
Description: tES device model Activadose II (North Coast Medical, Morgan Hill, CA, USA) programed to deliver tES.
Study NCT06411717 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microstructure lens A
Description: Subjects randomized to Trial Group A will be required to wear microstructural lens A (microstructural design type with low defocus ratio) for 12 months
Study NCT06411717 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microstructure lens B
Description: Subjects randomized to Trial B will be required to wear microstructural lens B (high defocus ratio microstructural design type) for 12 months
Study NCT06411717 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Subjects randomized to the control group will be required to wear aspherical single-light lenses for 12 months
Study NCT06419985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 80mg Ketamine HCl Prolonged Release
Description: Administration of Ketamine HCl Prolonged Release - 80mg
Study NCT06419985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 160mg Ketamine HCl Prolonged Release
Description: Administration of Ketamine HCl Prolonged Release - 160mg
Study NCT06419985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Administration of Ketamine HCl Prolonged Release - 240mg
Description: Administration of Ketamine HCl Prolonged Release - 240mg
Study NCT05549895 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 8 mg intrathecally
Study NCT05549895 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride
Description: 0.5 % intrathecally
Study NCT05549895 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Bupivacaine Hydrochloride
Description: 0.5 % intrathecally
Study NCT05555303 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Amikacin
Description: In addition to the all-oral RR-TB treatment, add two intramuscular doses each consisting of 30 mg amikacin/kg, a first dose on day 1 and a second dose on day 4, all in the first week of treatment.~The amikacin solution will be admixed with a lidocaine solution in the syringe before administration.
Study NCT04935996 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pleuropulmonary echography
Description: Pleuropulmonary echography is performed, in addition of the chest X-ray already performed in routine care
Study NCT06196385 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: intensive Cervical Traction
Description: A 30-minute cervical traction protocol, twice a day, for five consecutive days per week for 6 weeks. The main objective will be the evaluation of depression, insomnia, and quality of life. We evaluate at prior to the treatment and, at the end of the protocol, for depression, insomnia, and quality of life.
Study NCT06196385 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intensive Cervical Traction
Description: A 30-minute cervical traction protocol, twice a day, for five consecutive days per week for 6 weeks. The main objective will be the evaluation of depression, insomnia, and quality of life. We evaluate at prior to the treatment and, at the end of the protocol, for depression, insomnia, and quality of life.
Study NCT04870762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive standard of care
Study NCT04870762 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care
Study NCT04870762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Device Usage and Evaluation
Description: Wear 3D printed oral stent
Study NCT04870762 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical Device Usage and Evaluation
Description: Wear 3D printed oral stent
Study NCT05787340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bilişsel Egzersiz Terapi Yaklaşımı (BETY, Cognitive Exercise Therapy Approach)
Description: Bilişsel Egzersiz Terapi Yaklaşımı (BETY, Cognitive Exercise Therapy Approach) is a group exercise method that conforms to the biopsychosocial model via telerehabilitation.
Study NCT06343246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training with device
Description: : A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).
Study NCT06343246 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Inspiratory muscle training with device
Description: : A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).
Study NCT04283617 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensification of insulin regimen/Nutrition
Description: The intensification of the diabetes regimens will be managed by Dr. Sanchez Rangel, a fully trained attending endocrinologist, The weight goal will be to have no more than 5% weight change. Participants will have regular phone and in-person MD and nutritionist communication over the course of the 12-week study. All individuals will be asked to perform SMBG at least 4 times a day (before breakfast, lunch, dinner, and bedtime). The daily SMBG records will be sent to Dr. Sanchez Rangel weekly for review to guide adjustment of insulin regimens. Target blood glucose levels will be between 80-130 mg/dl before meals and between \< 180 mg/dl at bedtime. Throughout the study, individuals will be contacted via telephone call, email or through additional clinic visits as deemed necessary for maintenance of glycemic control. All individuals will receive education regarding the detection and proper management of hypoglycemia.
Study NCT05133024 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: concentrated beetroot juice
Description: Nitrate supplementation; natural source of dietary nitrate
Study NCT05133024 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: concentrated beetroot juice
Description: Nitrate supplementation; natural source of dietary nitrate
Study NCT04846673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg + Alpha-lipoic acid 480mg
Description: Pregabalin qd + alpha-lipoic acid qd
Study NCT04846673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Description: pregabalin qd
Study NCT06447558 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: palatal stimulation with a finger in premature infants
Description: Oral administration of breast milk droplets, palatal stimulation with a finger in premature infants
Study NCT04906122 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The grandmothers in the intervention group will be given breastfeeding counseling before discharge. Home monitoring will be performed in the 2nd week, 3rd and 6th months after the counseling.
Description: The research was planned as a randomized controlled study. Voluntary postpartum primiparous mothers who have recently given birth and their accompanying grandmothers will be randomly assigned to the intervention and control group. The grandmothers in the intervention group will be given breastfeeding counseling before discharge. Home monitoring will be performed in the 2nd week, 3rd and 6th months after the counseling. In each follow-up, breastfeeding knowledge and attitudes of the grandmothers, breastfeeding success of mothers, attitude towards breastfeeding, perception of postpartum support and newborn growth parameters will be determined. As a result of the research, the effect of breastfeeding training given to grandmothers will be evaluated breastfeeding status of the first 6 months, self-efficacy, attitude, social support perceptions, breastfeeding continuity and newborn growth parameters of primiparous mothers who have just given birth.
Study NCT06079788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adrenocorticotrophic Hormone
Description: For patients in complete remission, ACTH is given at a prednisone dose of 1.5-2mg/kg qod or 0.75-1mg/kg qd. ACTH 2 IU/kg/ day, qd,（the maximum dose ≤ 50 IU）, 28 days of continuous use for 5 days， for 24 weeks.~Prednisone: 5mg；Oral tablets; 1.5-2 mg/kg, qod or 0.75-1mg/kg/day,qd, then gradually taper the steroid by 0.25mg/kg qod or 0.125mg/kg qd every 4 weeks.If stable, taper to 5mg qod (body surface area > 1.0m2) and 2.5mg qod (body surface area \< 1.0m2) and maintain the dose until study completion.
Study NCT06079788 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Steroid
Description: For patients in complete remission, Prednisone: 5mg；Oral tablets; 1.5-2 mg/kg, qod or 0.75-1mg/kg/day,qd, then gradually taper the steroid by 0.25mg/kg qod or 0.125mg/kg qd every 4 weeks. If stable, taper to 5mg qod (body surface area > 1.0m2) and 2.5mg qod (body surface area \< 1.0m2) and maintain the dose until study completion.
Study NCT04895449 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-SARS-2-ST
Description: i.m. vaccine administration
Study NCT04846673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alpha-Lipoic Acid 480mg
Description: alpha-lipoic acid qd